Searched for
MODERNA VACCINE DEVELOPMENT
Three returnees from Ebola-hit African countries quarantined in Durg: Chhattisgarh Health Minister Shyam JaiswalChhattisgarh is fully prepared for potential virus infections. Health Minister Shyam Bihari Jaiswal assured that hospitals and quarantine f...- Women are the first caregivers in this Ebola outbreak and the most at riskEastern Congo faces a rapid Ebola outbreak. Women are primary caregivers, increasing their infection risk. Many lack protective gear, forci...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- Big blow to Moderna vaccine projects as Trump cancels over $700 million fundingThe Trump administration has slashed $766 million allocated in funding to Moderna Inc., an American biotech and pharmaceutical company resp...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Moderna says its COVID-19 vaccine protective, safe in young childrenModerna Inc said on Monday that its COVID-19 vaccine generated an immune response and was generally well-tolerated in children aged six to ...
- Moderna working on booster to combine COVID-19 vaccine with a flu shotFlu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...
- Covid-19 vaccine: Moderna offered legal indemnity, but with ridersThe proposal, which has been further sent to Moderna, will be taken up by its board of directors and once approved, will allow immediate im...
- India's drug regulator okays Cipla's imports of Moderna COVID-19 vaccineCipla will import vaccines that have been donated by the US company to India. "This will not be for a commercial supply. Cipla is facilitat...
- Close to commit over $1-bn to Moderna for COVID-19 booster vaccine; Provide price capping waiver, indemnity: Cipla to GovtCommending the government for its efforts to increase the vaccine availability in the country for achieving effective protection against CO...
- What is the Moderna COVID vaccine? Does it work, and is it safe?Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. T...
- Tata in talks to launch Moderna vaccine in IndiaTata Medical & Diagnostics, a newly formed subsidiary of Tata Sons, is said to have started initial discussions with US company Moderna for...
- Approval of 2nd COVID-19 vaccine another milestone in US' fight against pandemic: Joe BidenModerna's COVID-19 vaccine mRNA-1273 on Friday became the second drug in the US to get emergency use authorisation from the US FDA, a week ...
- India's likely to get access to Moderna's coronavirus vaccine via COVAX facilitySince Moderna received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), which is a part of COVAX, India may get dos...
- Moderna COVID-19 vaccine could be ready for use by end of year, US saysThe trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel co...
- Moderna extends lipids deal to boost COVID-19 vaccine outputModerna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet in...
- US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...
Load More
